Overview Of Beacon Health Options Drug Rehab Coverage

Beacon Health Options appeared in 2014 after a merger between Beacon Health Strategies and Value Options. Beacon Health Options, the largest privately held company in the United States, currently serves 50 million customers. Beacon health options drug rehab coverage has more than 350 customers, 41 of which are Fortune 500 companies. The company has partnerships with more than 100 external health plans.

Beacon Health Options Addiction Resources

Beacon Health Options maintains a team of medical staff to respond to all member and provider calls 24 hours a day, 7 days a week and 365 days a year. The company has developed a support network of medical professionals, as well as a framework for recovery-focused programs and effective partnerships. Beacon also runs the Health Options Stamp Out Stigma program, which aims to end the stigma associated with mental illness and substance abuse. All decisions are based on the company’s maintenance criteria.

Beacon Health Options Policy Protection for Substance Abuse

Beacon Health Options programs vary greatly in the type and quantity they offer for various medical needs. Most of the company’s programs offer some form of substance abuse treatment, and some programs primarily or exclusively provide that type of coverage. Because many beacon health options drug rehab coverageis offered in partnership with other health insurance providers, coverage of the other provider’s coverage may also be available to the company’s customers.

Should Treatment Centers Be In-Network?

Beacon health options should generally be within the treatment center network. Services provided by facilities outside the network usually have to be paid out of pocket. This can vary from project to project, especially in cases where the project is jointly offered by another provider. Beacon Health Options places many protections on emergency services and when the patient is sent by a provider to a blood sample, for example, outside the network, when the patient is being treated by a provider outside the network without the patient’s knowledge.

About Violet

Violet Rae Murphy: Violet, a biotech analyst, covers advances in health technology, biotech innovations, and the future of personalized medicine.
View all posts by Violet →